Clinical pattern of failure after a durable response to immune check inhibitors in non-small cell lung cancer patients

Although immune checkpoint inhibitors (ICIs) can induce durable responses in non-small-cell lung cancer (NSCLC) patients, a significant proportion of responders still experience progressive disease after a period of response. Limited data are available on the clinical patterns of acquired resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Heo, Ja Yoon, Yoo, Shin Hye, Suh, Koung Jin, Kim, Se Hyun, Kim, Yu Jung, Ock, Chan-Young, Kim, Miso, Keam, Bhumsuk, Kim, Tae Min, Kim, Dong-Wan, Heo, Dae Seog, Lee, Jong Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844257/
https://www.ncbi.nlm.nih.gov/pubmed/33510255
http://dx.doi.org/10.1038/s41598-021-81666-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844257/
https://www.ncbi.nlm.nih.gov/pubmed/33510255
http://dx.doi.org/10.1038/s41598-021-81666-x

Ejemplares similares